These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 446679)

  • 1. Properties of vascular permeability factor in human sera for guinea-pig skin.
    Yoshida H; Sato M; Kasukawa R; Yoshida T
    Experientia; 1979 May; 35(5):676-8. PubMed ID: 446679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig Hageman factor as a vascular permeability enhancement factor.
    Yamamoto T; Cochrane CG
    Am J Pathol; 1981 Nov; 105(2):164-75. PubMed ID: 6794374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor.
    Yamamoto T; Cochrane CG
    Am J Pathol; 1982 May; 107(2):127-34. PubMed ID: 7044129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in vascular permeability during allergic inflammatory responses in the skin and knee-joint of the guinea-pig.
    Morley J; Williams TJ
    J Pathol; 1971 Feb; 103(2):P8. PubMed ID: 5567929
    [No Abstract]   [Full Text] [Related]  

  • 5. A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.
    Lagrue G; Xheneumont S; Branellec A; Hirbec G; Weil B
    Biomedicine; 1975 Feb; 23(1):37-40. PubMed ID: 1174637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.
    Feng D; Nagy JA; Hipp J; Dvorak HF; Dvorak AM
    J Exp Med; 1996 May; 183(5):1981-6. PubMed ID: 8642308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of rate of extravasation of plasma protein in inflammatory responses in guinea-pig skin using a continuous recording method.
    Williams TJ; Morley J
    Br J Exp Pathol; 1974 Feb; 55(1):1-12. PubMed ID: 4835793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of substance P-induced increase in vascular permeability in guinea pig skin].
    Iwamoto I
    Arerugi; 1989 Mar; 38(3):239-45. PubMed ID: 2473726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.
    Sobel AT; Branellec AI; Blanc CJ; Lagrue GA
    J Immunol; 1977 Oct; 119(4):1230-4. PubMed ID: 894032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin.
    Muchitsch EM; Teschner W; Linnau Y; Pichler L
    Arch Int Pharmacodyn Ther; 1996; 331(3):313-21. PubMed ID: 9125002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin].
    Bodammer G; Vogt W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(3):255-60. PubMed ID: 4193283
    [No Abstract]   [Full Text] [Related]  

  • 12. Hageman factor dependent kinin generation system in guinea pig skin: extravascular localization of the components, and prolonged vascular reaction in inhibitor-depleted animal of this system.
    Yamamoto T; Ishimatsu T; Kambara T
    Adv Exp Med Biol; 1989; 247A():447-52. PubMed ID: 2603811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization. IV: Permeability changes during active and passive desensitization.
    Baba T; Yoshida T; Cohen S
    J Exp Pathol; 1984; 1(3):175-82. PubMed ID: 6599937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor).
    Yeo TK; Senger DR; Dvorak HF; Freter L; Yeo KT
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1568-75. PubMed ID: 1930196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
    Bruce JN; Criscuolo GR; Merrill MJ; Moquin RR; Blacklock JB; Oldfield EH
    J Neurosurg; 1987 Dec; 67(6):880-4. PubMed ID: 3681425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine 'skin reactive factor' (SRF) and the nephrotic syndrome.
    Lagrue G; Branellec A; Xheneumont S; Weil B
    Bibl Anat; 1975; 13():331-4. PubMed ID: 1231773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
    Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D
    J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.